Role of the B-cell response in recovery of mice from primary influenza virus infection

Immunological Reviews

Volumn 159, Issue , 1997, Pages 95-103

  Gerhard, Walter ^a   Mozdzanowska, Krystyna ^a   Furchner, Michelle ^a   Washko, George ^a   Maiese, Krista ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN M; VIRUS ANTIBODY; VIRUS HEMAGGLUTININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; B LYMPHOCYTE; CONTROLLED STUDY; INFLUENZA; INFLUENZA VIRUS; LUNG INFECTION; MOUSE; NONHUMAN; NOSE INFECTION; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; REVIEW; SCID MOUSE; T LYMPHOCYTE; VIRUS IMMUNITY; VIRUS NEUTRALIZATION;

EID: 0030722677     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1997.tb01009.x     Document Type: Review

References (69)

1. Webster RG, Rott R. Influenza virus A pathogenicity: the pivotal role of hemagglutinin. Cell 1987;50:665-666.
2. Boycott R, Klenk HD, Ohuchi M. Cell tropism of influenza virus mediated by hemagglutinin activation at the stage of virus entry. Virology 1994;203:313-319.
3. Sweet C, Smith H. Pathogenicity of influenza virus. Microbiol Rev 1980;44:303-330.
4. Eichelberger MC, Wang M, Allan W, Webster RG, Doherty PC. Influenza virus RNA in the lung and lymphoid tissue of immunologically intact and CD4-depleted mice. J Gen Virol 1991;72:1695-1698.
5. Wells MA, Ennis FA, Albrecht P. Recovery from a viral respiratory infection. II. Passive transfer of immune spleen cells to mice with influenza pneumonia. J Immunol 1981;126:1042-1047.
6. Zinkernagel RM, Doherty PC. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T cell restriction-specificity, function and responsiveness. Adv Immunol 1979;27:51-77.
7. Yap KL, Ada GL, McKenzie IFC. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 1978;173:238-239.
8. Lukacher AE, Braciale VL, Braciale TJ. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med 1984;160:814-826.
9. Mackenzie CD, Taylor PM, Askonas BA. Rapid recovery of lung histology correlates with clearance of influenza virus by specific CD8 cytotoxic T cells. Immunology 1989;67:375-381.
10. Eichelberger M, Allan W, Zijlstra M, Jaenisch R, Doherty PC. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8 T cells. J Exp Med 1991;174:875-880.
11. Scherle PA, Palladino G, Gerhard W. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J Immunol 1992;148:212-217.
12. Bender BS, Croghan T, Zhang L, Small PA. Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med 1992;175:1143-1145.
13. Doherty PC, Allan W, Eichelberger M, Carding SR. Roles of αβ and γδ cell subsets in viral immunity. Annu Rev Immunol 1992;10:123-151.
14. Hou S, Doherty PC. Clearance of Sendai virus by CD8 T cells requires direct targeting to virus-infected epithelium. Eur J Immunol 1995;25:111-116.
15. Topham DJ, Tripp RA, Sarawar SR, Sangster MY, Doherty PC. Immune CD4 T cells promote the clearance of influenza virus from major histocompatibility complex class II-/- respiratory epithelium. J Virol 1996;70:1288-1291.
16. Iwasaki T, Nozima T. Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production. J Immunol 1977;118:256-263.
17. Kris RM, Asofsky R, Evans CB, Small PA. Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM. J Immunol 1985;134:1230-1235.
18. Kitamura D, Roes J, Kuhn R, Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 1991;350:423-426.
19. H locus. Int Immunol 1993;6:647-656.
20. Graham MB, Braciale TJ. Influenza virus clearance in B lymphocyte deficient mice. In: Brown LE, Hampson AW, Webster RG, eds. Options for the control of influenza III. Amsterdam: Elsevier Science B.V. 1996. p.166-169.
21. + T cell memory in the absence of B cells and Ig. J Immunol 1996;157:2947-2952.
22. Liles WC, Van Voorhis WC. Review: Nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J Infect Dis 1995;172:1573-1580.
23. Krieger JI, Grammer SF, Grey HM, Chestnut RW Antigen presentation by splenic B cells: resting B cells are ineffective, whereas activated B cells are effective accessory cells for T cell responses. J Immunol 1985;135:2937-2945.
24. Liu Y, et al. Gene-targeted B-deficient mice reveal a critical role for B cells in the CD4 T cell response. Int Immunol 1995;7:1353-1362.
25. + T cells to protein antigens in vivo. J Immunol 1995;155:3734-3741.
26. Epstein MM, Di Rosa F, Jankovic D, Sher A, Matzinger P. Successful T cell priming in B cell-deficient mice. J Exp Med 1995;182:915-922.
27. + T cell activation and tolerance induction in B cell knockout mice. J Exp Med 1996;183:1339-1344.
28. Justewicz AM, Doherty PC, Webster RG. The B-cell response in lymphoid tissue of mice immunized with various antigenic forms of the influenza virus hemagglutinin. J Virol 1995;69:5414-5421.
29. Lightman S, Cobbold S, Waldmann H, Askonas BA. Do L3T4 T cells act as effector cells in protection against influenza virus infection? Immunology 1987;62:139-144.
30. + T cell clones vary in function in vitro and in influenza infection in vivo. Int Immunol 1990;2:323-328.
31. + T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J Exp Med 1994;180:1273-1282.
32. Carding SR, Allan W, McMickle A, Doherty PC. Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia. J Exp Med 1993;177:475-482.
33. Ramsay AJ, Ruby J, Ramshaw IA. A case for cytokines as effector molecules in the resolution of virus infection. Immunol Today 1993;14:155-157.
34. Kundig TM, Hengartner H, Zinkernagel RM. T cell-dependent IFN-γ exerts an antiviral effect in the central nervous system but not in peripheral solid organs. J Immunol 1993;150:2316-2321.
35. Schulman JL, Petrigrow C, Woodruff J. Effects of cell mediated immunity in influenza virus infections in mice. Dev Biol Stand 1977;39:385-390.
36. Kris RM, Yetter RA, Cogliano R, Ramphal R. Small PA. Passive serum antibody caused temporary recovery from influenza virus infection of the nose, trachea and lung of nude mice. Immunology 1988;63:349-353.
37. Virelizier JL. Host defenses against influenza virus: the role of antihemagglutinin antibody. J Immunol 1975;115:434-439.
38. Virelizier JL, Allison AC, Schild GC. Immune responses to influenza virus in the mouse and their role in control of the infection. Br Med Bull 1979;35:65-68.
39. Askonas BA, McMichael AJ, Webster RG. The immune response to influenza viruses and the problem of protection against infection. In: Beare AS, ed. Basic and applied influenza research. Boca Raton: CRC Press, Inc. 1982. p.159-188.
40. Virelizier JL, Allison AC, Oxford JS, Schild GC. Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells. Nature 1977;266:52-54.
41. Yewdell JW, Frank E, Gerhard W. Expression of influenza A virus internal antigens on the surface of infected P815 cells. J Immunol 1981;126:1814-1819.
42. Stitz L, Schmitz C, Binder D, Zinkernagel R, Paoletti E, Becht H. Characterization and immunological properties of influenza A virus nucleoprotein (NP):cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection. J Gen Virol 1990;71:1169-1179.
43. Hackett CJ, Askonas BA, Webster RG, Van Wyke K. Monoclonal antibodies to influenza matrix protein: detection of low levels of matrix protein on abortively infected cells. J Gen Virol 1980;47:497-501.
44. Treanor JJ, Tierney EL, Zebedee SL, Lamb RA, Murphy BR. Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J Virol 1990;64:1375-1377.
45. Denkers EY, Badger CC, Ledbetter JA, Bernstein ID. Influence of antibody isotype on passive serotherapy of lymphoma. J Immunol 1985;135:2183-2186.
46. Kaminski MS, Kitamura K, Maloney DG, Campbell MJ, Levy R. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants. J Immunol 1986;136:1123-1130.
47. Waldor MK, Mitchell D, Kipps TJ, Herzenberg LA, Steinman L. Importance of immunoglobulin isotype in therapy of experimental autoimmune encephalitis with monoclonal anti-CD4 antibodies. J Immunol 1987;139:3660-3664.
48. Palladino G, Mozdzanowska K, Washko G, Gerhard W. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J Virol 1995;69:2075-2081.
49. Brandtzaeg P. Overview of the mucosal immune system. Curr Top Microbiol Immunol 1989;146: 13-24.
50. Kaltreider HB. Expression of immune mechanisms in the lung. Am Rev Resp Dis 1976;113:347-379.
51. Renegar KB, Small PA. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J Virol 1991;65:2146-2148.
52. Ramphal R, Cogliano RC, Shands JW, Small PA. Serum antibody prevents lethal murine influenza pneumonitis but not tracheitis. Infect Immun 1979;25:992-997.
53. Prince GA, Horswood RL, Chanock RM. Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. J Virol 1985;55:517-520.
54. + T cells. J Immunol 1990;144:3980-3986.
55. Baumgarth N, Kelsoe A. Functionally distinct T cells in three compartments of the respiratory tract after influenza virus infection. Eur J Immunol 1996;26:2189-2197.
56. Owens SL, Osebold JW, Zee YC. Dynamics of B-lymphocytes in the lungs of mice exposed to aerosolized influenza virus. Infect Immun 1981;33:231-238.
57. Dimmock NJ. Neutralization of animal viruses. New York: Springer Verlag; 1993.
58. Mozdzanowska K, Furchner M, Washko G, Mozdzanowsi J, Gerhard W. A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro. J Virol 1997;71:4347-4355.
59. Bachmann MF, Kunding TM, Kalberer CP, Hengartner H, Zinkernagel RM. How many specific B cells are needed to protect against a virus? J Immunol 1994;152:4235-4241.
60. Kavaler J, Caton AJ, Staudt LM, Gerhard W. A B cell population that dominates the primary response to influenza virus hemagglutinin does not participate in the memory response. Eur J Immunol 1991;21:2687-2695.
61. Kavaler J, Caton AJ, Staudt LM, Schwartz D, Gerhard W. A set of closely related antibodies dominates the primary antibody response to the antigenic site Cb of the A/PR/8/34 influenza virus hemagglutinin. J Immunol 1990;145:2312-2321.
62. Kalinke U, et al. The role of somatic mutation in the generation of the protective humoral immune response against Vesicular Stomatitis virus. Immunity 1996;5:639-652.
63. Sarawar SR, Sangster M, Coffman RL, Doherty PC. Administration of anti-IFN-γ antibody to β2-microglobulin-deficient mice delays influenza virus clearance but does not switch the response to a T helper cell 2 phenotype. J Immunol 1994;153:1246-1253.
64. Shvartsman YS, Zykov MP. Secretory anti-influenza immunity. Adv Immunol 1976;22:291-330.
65. Couch RB, Kasel JA. Immunity to influenza in man. Annu Rev Microbiol 1983;37:529-549.
66. Ada GL, Jones PD. The immune response to influenza infection. Curr Top Microbiol Immunol 1986;128: 1-54.
67. Murphy BR, Clements ML. The systemic and mucosal immune response of humans to influenza A virus. Curr Top Microbiol Immunol 1989;146: 107-115.
68. Liang S, Mozdzanowska K, Palladino G, Gerhard W. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J Immunol 1994;152:1653-1661.
69. Bachmann MF, Kunding TM, Hengartner H, Zinkernagel RM. Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? Proc Natl Acad Sci USA 1997;94:640-645.